Search

Your search keyword '"Battistella, M."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Battistella, M." Remove constraint Author: "Battistella, M." Topic lymphoma, t-cell, cutaneous Remove constraint Topic: lymphoma, t-cell, cutaneous
40 results on '"Battistella, M."'

Search Results

1. Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.

2. Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas.

3. Pathophysiology of cutaneous T-cell lymphomas: Perspective from a French referral centre.

4. Failure of second challenge with mogamulizumab in C-C chemokine receptor 4-positive cutaneous T-cell lymphoma.

5. Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.

6. KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

7. Exploring the Nonlymphocytic Cutaneous Microenvironment in Advanced Cutaneous T-Cell Lymphomas using Single-Cell RNA Sequencing.

8. CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas.

9. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.

10. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.

11. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.

12. Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group.

14. CCR8 is a new therapeutic target in cutaneous T-cell lymphomas.

15. Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.

16. Clinical, histopathological and prognostic features of primary cutaneous acral CD8 + T-cell lymphoma and other dermal CD8 + cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop.

17. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.

18. Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

19. Recent advances on cutaneous lymphoma epidemiology.

21. Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma.

22. [Impact of algorithms proposed by the Cutaneous Lymphoma French Study Group for diagnosis of cutaneous lymphoproliferations].

23. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.

24. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features.

25. Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.

26. [Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].

27. Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.

28. Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas.

29. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.

30. KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting.

31. [Granulomatous slack skin associated with metastatic testicular seminoma].

32. Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging.

33. Granulomatous slack skin T-cell lymphoma: an important differential diagnosis with giant cell tumor of soft tissue.

34. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas.

35. Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas.

36. [Management of cutaneous lymphoma ].

37. [Cutaneous lymphoma at the Dermatology Day conference, Paris 2010].

38. [Therapeutic perspectives of cutaneous T-cell lymphoma].

39. Two atypical cases of cutaneous gamma/delta T-cell lymphomas.

40. Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop*

Catalog

Books, media, physical & digital resources